Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment. Issue 6 (12th May 2022)

Record Type:: Journal Article
Title:: Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment. Issue 6 (12th May 2022)
Main Title:: Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment
Authors:: Bellesi, Silvia
Sali, Michela
Maiolo, Elena
Pereyra Boza, Maria del Carmen
Alma, Eleonora
Palucci, Ivana
Fatone, Federica
De Maio, Flavio
Viscovo, Marcello
D'Alò, Francesco
De Stefano, Valerio
Hohaus, Stefan
Sanguinetti, Maurizio
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 63:Issue 6(2022)
Journal:: Leukemia & lymphoma
Issue:: Volume 63:Issue 6(2022)
Issue Display:: Volume 63, Issue 6 (2022)
Year:: 2022
Volume:: 63
Issue:: 6
Issue Sort Value:: 2022-0063-0006-0000
Page Start:: 1474
Page End:: 1478
Publication Date:: 2022-05-12
Subjects:: COVID-19 -- mRNA vaccine -- Lymphoma -- anti-CD20 immunotherapy -- CD19+ B lymphocytes
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2022.2032042 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21745.xml